Psyence Biomedical Equity Warrants Exp 22 Jan 2029 logo

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Share Price Today

(NASDAQ: PBMWW)

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price is $0.01 & ₹0.85 as on 18 Apr 2025, 2.30 'hrs' IST

$0.01

Market is closed - opens 7 PM, 21 Apr 2025

View live Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price in Dollar and Rupees. Guide to invest in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Psyence Biomedical Equity Warrants Exp 22 Jan 2029, along with analyst recommendations, forecasts, and comprehensive financials.

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price movements

  • Today's Low: $0.01
    Today's High: $0.01

    Day's Volatility :9.09%

  • 52 Weeks Low: $0.00
    52 Weeks High: $0.12

    52 Weeks Volatility :97.12%

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) Returns

PeriodPsyence Biomedical Equity Warrants Exp 22 Jan 2029Index (Russel 2000)
3 Months
-31.33%
0.0%
6 Months
-74.12%
0.0%
1 Year
-91.42%
0.0%
3 Years
-79.4%
-12.9%

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) Key Statistics

in dollars & INR

Previous Close
$0.0108
Open
$0.0104
Today's High
$0.011
Today's Low
$0.01
Today's Volume
$22.7K
52 Week High
$0.1249
52 Week Low
$0.0036
Revenue TTM
$0.0
EBITDA
$-2.8M
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock (PBMWW) from India?

It is very easy for Indian residents to invest directly in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock in both Indian Rupees (INR) and US Dollars (USD). Search for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 or PBMWW on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 shares which would translate to 85.465 fractional shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Psyence Biomedical Equity Warrants Exp 22 Jan 2029, in just a few clicks!

Returns in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) for Indian investors in Rupees

The Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 investment value today

Current value as on today

₹10,674

Returns

₹89,326

(-89.33%)

Returns from Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock

₹91,667 (-91.67%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW)

1275.0%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Investment in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Shares from India has grown by 1275.0% over the past 30 days, indicating increased transactional activity.

29%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Psyence Biomedical Equity Warrants Exp 22 Jan 2029

Rating
Trend

Insights on Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock (Ticker Symbol: PBMWW)

  • Price Movement

    In the last 7 days, PBMWW stock has moved down by -45.7%
  • PBMWW vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 167.1%

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Technicals Summary

Sell

Neutral

Buy

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 logo
-38.29%
-74.12%
-91.42%
-79.4%
-79.4%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Psyence Biomedical Equity Warrants Exp 22 Jan 2029

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Organization
Psyence Biomedical Equity Warrants Exp 22 Jan 2029
Employees
0
CEO
Dr. Neil Maresky M.D.
Industry
Miscellaneous

Management People of Psyence Biomedical Equity Warrants Exp 22 Jan 2029

NameTitle
Mr. Jody Aufrichtig
Co-Founder, Executive Chairman & Strategic Business Development Officer
Dr. Neil Maresky M.D.
CEO & Director
Mr. Warwick Ron Corden-Lloyd
Chief Financial Officer
Ms. Taryn Vos
General Counsel

Important FAQs about investing in PBMWW Stock from India :

What is Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price today?

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price today stands at $0.01, Open: $0.01 ; Previous Close: $0.01 ; High: $0.01 ; Low: $0.01 ; 52 Week High: $0.12 ; 52 Week Low: $0.00.

The stock opens at $0.01, after a previous close of $0.01. The stock reached a daily high of $0.01 and a low of $0.01, with a 52-week high of $0.12 and a 52-week low of $0.00.

Can Indians buy Psyence Biomedical Equity Warrants Exp 22 Jan 2029 shares?

Yes, Indians can invest in the Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) from India.

With INDmoney, you can buy Psyence Biomedical Equity Warrants Exp 22 Jan 2029 at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Psyence Biomedical Equity Warrants Exp 22 Jan 2029 at zero transaction cost.

How can I buy Psyence Biomedical Equity Warrants Exp 22 Jan 2029 shares from India?

It is very easy to buy Psyence Biomedical Equity Warrants Exp 22 Jan 2029 from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) be purchased?

Yes, you can buy fractional shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 with INDmoney app.

What are the documents required to start investing in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stocks?

To start investing in Psyence Biomedical Equity Warrants Exp 22 Jan 2029, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock (PBMWW)?

Today’s highest price of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) is $0.01.

Today’s lowest price of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) is $0.01.

What is today's market capitalisation of Psyence Biomedical Equity Warrants Exp 22 Jan 2029?

Today's market capitalisation of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 PBMWW is 6.9M

What is the 52 Week High and Low Range of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock (PBMWW)?

  • 52 Week High

    $0.12

  • 52 Week Low

    $0.00

What are the historical returns of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW)?

  • 1 Month Returns

    -38.29%

  • 3 Months Returns

    -74.12%

  • 1 Year Returns

    -91.42%

  • 5 Years Returns

    -79.4%

Who is the Chief Executive Officer (CEO) of Psyence Biomedical Equity Warrants Exp 22 Jan 2029 ?

Dr. Neil Maresky M.D. is the current Chief Executive Officer (CEO) of Psyence Biomedical Equity Warrants Exp 22 Jan 2029.